Flexible Solutions International profit margin FSI
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −8.8%
- Operating margin, 12 months
- −2.6%
- Net margin on a year earlier
- −16.9 pts
- Peer median
- 6.2%
Over the twelve months to Jun 30, 2026, Flexible Solutions International kept −8.8% of its revenue as net profit, with an operating margin of −2.6% and a gross margin of 19.1%.
Five years earlier its net margin was 10.2%.
The median for 3 chemicals stocks of a similar size is 6.2%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 2.0% | 11.9% | 32.6% |
| FY2024 | 7.9% | 14.4% | 34.6% |
| FY2023 | 7.2% | 7.8% | 27.2% |
| FY2022 | 15.3% | 15.4% | 30.3% |
| FY2021 | 10.0% | 15.9% | 33.1% |
| FY2020 | 9.5% | 13.1% | 31.1% |
| FY2019 | 7.0% | 7.0% | 31.4% |
| FY2018 | 14.0% | 7.3% | 31.6% |
| FY2017 | 11.3% | 9.8% | 38.6% |
| FY2016 | 11.0% | n/a | 43.0% |
| FY2015 | 9.5% | n/a | 39.0% |
| FY2014 | 2.5% | n/a | 32.3% |
| FY2013 | 11.5% | n/a | 28.7% |
| FY2012 | −6.6% | −0.2% | 32.1% |
| FY2011 | 1.2% | 8.4% | 37.7% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −8.8% | −16.9 pts | −2.6% | |
| Q1 FY26 | 2.1% | −4.2 pts | 11.7% | |
| Q4 FY25 | 2.0% | −5.9 pts | 11.9% | |
| Q3 FY25 | 5.0% | −5.8 pts | 11.4% | |
| Q2 FY25 | 8.2% | +0.7 pts | 16.1% | |
| Q1 FY25 | 6.3% | +0.1 pts | 12.8% | |
| Q4 FY24 | 7.9% | +0.7 pts | 14.4% | |
| Q3 FY24 | 10.8% | +1.8 pts | 15.1% | |
| Q2 FY24 | 7.5% | −5.1 pts | 9.2% | |
| Q1 FY24 | 6.2% | −8.0 pts | 6.9% | |
| Q4 FY23 | 7.2% | −8.1 pts | 7.8% | |
| Q3 FY23 | 9.0% | −0.3 pts | 7.5% |
Against its peers
Companies in Chemicals nearest Flexible Solutions International's size, closest first, today.
| Company | Profit margin |
|---|---|
| FSIFlexible Solutions International | −8.8% |
| FTLFFitlife Brands | 6.2% |
| BTMDbiote | 3.2% |
| NAGENiagen Bioscience | 12.4% |
| Peer median | 6.2% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Flexible Solutions International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.